retatrutide weight loss efficacy trial data New Phase 3 just dropped 👀 Eli Lilly's reported average approaching 30%, with some patients achieving results Retatrutide Surpasses Tirzepatide in Weight

Results were striking

Improves Insulin Sensitivity: Reduces fat storage and supports overall metabolic well-being

Some patients report noticeable improvements in pain, mobility, and function within 2 to 4 weeks, while others can take up to 12 weeks or longer to see measurable progress

female who requested liposuction of her arms and shoulders

Common Digestive Changes Patients Notice As gut motility slows, some patients experience: Constipation Bloating or pressure after meals Early fullness Mild nausea Reduced hunger cues These effects are most common during dose increases or early treatment and usually improve with proper support